Monitoring of anti-TNF biological treatments

Monitoring of anti-TNF biological treatments

Bibliographic Details
Main Authors:	Ramiro S, Novalbos L, Ramos I, Balsa A, Pascual-Salcedo D, Ruiz del Agua A, Martínez A, Simón L, Nagore D
Format:	Article
Language:	English
Published:	BMC 2010-11-01
Series:	Journal of Translational Medicine

Similar Items

Biological Treatments in Behçet’s Disease: Beyond Anti-TNF Therapy
by: Francesco Caso, et al.
Published: (2014-01-01)

Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)
by: A. Nassar-Sheikh Rashid, et al.
Published: (2021-04-01)

Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies
by: Katarzyna Bogunia-Kubik, et al.
Published: (2021-07-01)

BIOLOGICAL EFFECTS OF TNF-BINDING VARIOLAVIRUS RECOMBINANT PROTEIN
by: I. A. Orlovskaya, et al.
Published: (2014-07-01)

Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis
by: I. Olivieri, et al.
Published: (2013-03-01)

A review of ocular adverse events of biological anti-TNF drugs
by: Fernanda Nicolela Susanna, et al.
Published: (2020-04-01)

Understanding the biology and use of anti-TNF agents in JIA – interim results
by: Lovell Daniel J, et al.
Published: (2012-07-01)

Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-α biologicals and an Infliximab-biosimilar.
by: D J Buurman, et al.
Published: (2018-01-01)

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
by: Borja Hernández-Breijo, et al.
Published: (2021-06-01)

A Neurologist’s Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease
by: Ian A. Clark, et al.
Published: (2015-01-01)

Properties of Fluorescent Far-Red Anti-TNF Nanobodies
by: Ekaterina N. Gorshkova, et al.
Published: (2018-12-01)

Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
by: Ping Li, et al.
Published: (2017-07-01)

Biology of Inflammation in Crohn's Disease: Mechanisms of Action of Anti-TNF-αAlpha Therapy
by: Stephan R Targan
Published: (2000-01-01)

Review: Predicting response to anti-TNF agents for the treatment of Crohn's disease
by: Corey A. Siegel, et al.
Published: (2009-07-01)

Biologics targeted at TNF: design, production and challenges Biologics targeted at TNF: design, production and challenges
by: B. Gatto
Published: (2011-09-01)

Effectiveness of anti-TNF-α agents in the treatment of refractory juvenile dermatomyositis
by: Ryder C, et al.
Published: (2011-09-01)

Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
by: Przemyslaw J. Kotyla
Published: (2018-06-01)

Cronkhite-Canada Syndrome: Sustained Clinical Response with Anti-TNF Therapy
by: S. A. Taylor, et al.
Published: (2018-01-01)

ANTI-CYTOKINE (ANTI-TNF-ALPHA) THERAPY IN OPHTHALMOLOGY (REVIEW OF LITERATURE)
by: N. A. Gavrilopva, et al.
Published: (2015-12-01)

Anti-cytokine (anti-TNF-alpha) therapy in ophthalmology (review of literature)
by: N.A. Gavrilopva, et al.
Published: (2013-02-01)

ANTI-TNF THERAPY PERSPECTIVES IN RHEUMATOLOGIC PRACTICE
by: E.I. Alexeeva, et al.
Published: (2008-01-01)

ANTI-TNF THERAPY PERSPECTIVES IN RHEUMATOLOGIC PRACTICE
by: E.I. Alexeeva, et al.
Published: (2008-01-01)

Different effects of anti-TNF-alpha biologic drugs on the small bowel macroscopic inflammation in patients with ankylosing spondylitis
by: Chitul A., et al.
Published: (2017-03-01)

Pulmonary and intracranial miliary tuberculosis secondary to Behçet's anti-TNF alfa treatment
by: Asmae Sekkat, MD, et al.
Published: (2021-02-01)

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
by: Borja Hernández-Breijo, et al.
Published: (2019-02-01)

Anti-TNF treatment and miliary tuberculosis in Crohn’s disease
by: Milenković Branislava, et al.
Published: (2011-01-01)

Anti-TNF-α Compounds as a Treatment for Depression
by: Sarit Uzzan, et al.
Published: (2021-04-01)

Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis.
by: Erik J M Toonen, et al.
Published: (2012-01-01)

Assessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug Screening.
by: Sutthirat Udommethaporn, et al.
Published: (2016-01-01)

Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical Proteins.
by: Benjamin J Andrick, et al.
Published: (2015-01-01)

Anti-TNF Therapy and Malignancy – A Critical Review
by: Roger B Cohen, et al.
Published: (2001-01-01)

Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
by: Lydia Ntari, et al.
Published: (2021-04-01)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
by: Gaelle Vial, et al.
Published: (2021-01-01)

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
by: Borja Hernández-Breijo, et al.
Published: (2021-06-01)

Recommendations for starting anti TNF-α in patients with ankylosing spondylitis
by: L. Olivieri, et al.
Published: (2003-12-01)

Anti-TNF-alpha-induced lupus
by: Michel De Bandt
Published: (2019-11-01)

Farmacoeconomic impact of anti-TNFα
by: E. Vaccaro, et al.
Published: (2011-09-01)

Anti-TNF Therapy in Crohn’s Disease
by: Samuel O. Adegbola, et al.
Published: (2018-07-01)

Listeria Rhombencephalitis Complicating Anti-TNF Treatment during an Acute Flare of Crohn’s Colitis
by: L. Stratton, et al.
Published: (2016-01-01)

Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy
by: Francesco Ursini, et al.
Published: (2015-01-01)